Pharmacia Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Summary of Product Characteristics last updated on the eMC: 03/03/2009
SPC Synphase Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/03/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Feb-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Section 9 - revised renewal date

Section 10 - date of revision of text

- date of revision of text
Updated on 07/08/2007 and displayed until 03/03/2009
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   04/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 7 - MARKETING AUTHORIZATION HOLDER

 

Change in MAH address from Milton Keynes to Sandwich.

Updated on 24/01/2005 and displayed until 07/08/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/01/2005 and displayed until 24/01/2005
Reasons for adding or updating:
  • Change from the BAN of the active substance to the rINN
Updated on 12/12/2002 and displayed until 24/01/2005
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MA number
  • Change to section 10 (date of (partial) revision of the text
Updated on 04/03/2002 and displayed until 12/12/2002
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 10 (date of (partial) revision of the text

Active Ingredients/Generics

 
   norethisterone
   ethinylestradiol